Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublications en collaboration avec des chercheurs de Centro de Investigación Médica Aplicada (16)
2024
-
Dendritic Cells in Cancer Immunology and Immunotherapy
Cancers, Vol. 16, Núm. 5
2022
-
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Cancers, Vol. 14, Núm. 12
-
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
Frontiers in Immunology, Vol. 13
-
Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19
Chest, Vol. 162, Núm. 5, pp. 1006-1016
2021
-
Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8
Journal of Pathology, Vol. 255, Núm. 2, pp. 190-201
2020
-
Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence
Modern Pathology, Vol. 33, Núm. 12, pp. 2507-2519
2019
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
-
Programmed death–ligand 1 expression on direct Pap-stained cytology smears from non–small cell lung cancer: Comparison with cell blocks and surgical resection specimens
Cancer Cytopathology, Vol. 127, Núm. 7, pp. 470-480
2018
-
Cytology smears in the era of molecular biomarkers in non-small cell lung cancer doing more with less
Archives of Pathology and Laboratory Medicine
-
Erratum: Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial (Brachytherapy (2018) 17(5) (734–741), (S1538472118300898) (10.1016/j.brachy.2018.04.007))
Brachytherapy
-
Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial
Brachytherapy, Vol. 17, Núm. 5, pp. 734-741
2017
-
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Journal of Translational Medicine, Vol. 15, Núm. 1
-
EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
Journal of Hematology and Oncology, Vol. 10, Núm. 1, pp. 1-12
2015
-
Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis
Journal of Translational Medicine, Vol. 13, Núm. 1
2014
-
Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed
Journal of Translational Medicine, Vol. 12, Núm. 1
2012
-
La estadificación con resonancia magnética puede cambiar el manejo terapéutico en el cáncer de mama
Radiologia, Vol. 54, Núm. 4, pp. 350-356